Further characterization of Borjeson-Forssman-Lehmann syndrome in females due to de novo variants in PHF6.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Gerber, Celine B.
  • Fliedner, Anna
  • Bartsch, Oliver
  • Berland, Siren
  • Dewenter, Malin
  • Haug, Marte
  • Hayes, Ian
  • Marin-Reina, Purificacion
  • Mark, Paul R.
  • Maystadt, Isabelle
  • Karadurmus, Deniz
  • Steindl, Katharina
  • Wiesener, Antje
  • Zweier, Markus
  • Sticht, Heinrich
  • Zweier, Christiane

Grupos

Abstract

While inherited hemizygous variants in PHF6 cause X-linked recessive Borjeson-Forssman-Lehmann syndrome (BFLS) in males, de novo heterozygous variants in females are associated with an overlapping but distinct phenotype, including moderate to severe intellectual disability, characteristic facial dysmorphism, dental, finger and toe anomalies, and linear skin pigmentation. By personal communication with colleagues, we assembled 11 additional females with BFLS due to variants in PHF6. We confirm the distinct phenotype to include variable intellectual disability, recognizable facial dysmorphism and other anomalies. We observed skewed X-inactivation in blood and streaky skin pigmentation compatible with functional mosaicism. Variants occurred de novo in 10 individuals, of whom one was only mildly affected and transmitted it to her more severely affected daughter. The mutational spectrum comprises a two-exon deletion, five truncating, one splice-site and three missense variants, the latter all located in the PHD2 domain and predicted to severely destabilize the domain structure. This observation supports the hypothesis of more severe variants in females contributing to gender-specific phenotypes in addition to or in combination with effects of X-inactivation and functional mosaicism. Therefore, our findings further delineate the clinical and mutational spectrum of female BFLS and provide further insights into possible genotype-phenotype correlations between females and males.

© 2022 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.

Datos de la publicación

ISSN/ISSNe:
0009-9163, 1399-0004

CLINICAL GENETICS  WILEY

Tipo:
Article
Páginas:
182-190
Factor de Impacto:
1,192 SCImago
Cuartil:
Q2 SCImago

Citas Recibidas en Web of Science: 3

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Borjeson-Forssman-Lehmann syndrome; PHF6; X-chromosomal; de novo

Proyectos asociados

RED DE BIOBANCOS (BIOBANCOS)

RD09/0076/00021 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2010

COMPREHENSIVE, INTEGRATIVE AND GENOMIC APPROACH TO THE UNDERSTANDING AND TREATMENT OF CANCER AND LEUKEMIA.

Investigador Principal: MIGUEL ÁNGEL SANZ ALONSO

PIE13/00046 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014

LA RUTA DE LA OXITOCINA EN LOS TRASTORNOS DEL ESPECTRO AUTISTA: IMPORTANCIA DE LAS VARIANTES GENÉTICAS CON RELEVANCIA FUNCIONAL.

Investigador Principal: CARMEN ORELLANA ALONSO

2014_0056_CRC_ORELLANA . 2014

ABORDAJE GENÓMICO PARA LA IDENTIFICACIÓN DE NUEVOS GENES Y MÓDULOS FUNCIONALES RESPONSABLES DE DISCAPACIDAD INTELECTUAL GRAVE.

Investigador Principal: FRANCISCO MARTÍNEZ CASTELLANO

PI14/00350 . INSTITUTO DE SALUD CARLOS III . 2015

NUEVA APROXIMACIÓN GENÓMICA PARA EL DIAGNÓSTICO DE AUTISMO Y DISCAPACIDAD INTELECTUAL: IMPORTANCIA DE LAS MUTACIONES ADQUIRIDAS EN MOSAICISMO SOMÁTICO Y DE NUEVOS GENES CANDIDATOS.

Investigador Principal: SANDRA MONFORT MEMBRADO

2018_0170_CRC_MUTUA MADRILEÑA_MONFORT . FUNDACION MUTUA MADRILEÑA . 2018

Cita

Compartir